SIS Stock Overview
Science in Sport plc, together with its subsidiaries, develops, manufactures, and markets sports nutrition products for professional athletes, sports and fitness enthusiasts, and the active lifestyle community.
Science in Sport Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||UK£0.16|
|52 Week High||UK£0.78|
|52 Week Low||UK£0.16|
|1 Month Change||-44.83%|
|3 Month Change||-65.22%|
|1 Year Change||-79.22%|
|3 Year Change||-68.63%|
|5 Year Change||-77.31%|
|Change since IPO||-73.55%|
Recent News & Updates
|SIS||GB Personal Products||GB Market|
Return vs Industry: SIS underperformed the UK Personal Products industry which returned -0.9% over the past year.
Return vs Market: SIS underperformed the UK Market which returned -15.2% over the past year.
|SIS Average Weekly Movement||11.3%|
|Personal Products Industry Average Movement||6.8%|
|Market Average Movement||5.5%|
|10% most volatile stocks in GB Market||10.8%|
|10% least volatile stocks in GB Market||2.9%|
Stable Share Price: SIS is more volatile than 90% of UK stocks over the past 3 months, typically moving +/- 11% a week.
Volatility Over Time: SIS's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
Science in Sport plc, together with its subsidiaries, develops, manufactures, and markets sports nutrition products for professional athletes, sports and fitness enthusiasts, and the active lifestyle community. The company offers energy bars, gels, powders, and shots; hydration products, such as gels, tablets, and powders; recovery products; supplements; and vitamins. It sells its products under the PhD Nutrition and Science in Sport brand names through retail distribution, including supermarkets and high street chains; specialist sports retailers; grocers; convenience and discount retailers; and international wholesalers, retailers, and distributors, as well as phd.com and scienceinsport.com digital platforms, third-party online sites in the United Kingdom, rest of Europe, the United States, and internationally.
Science in Sport Fundamentals Summary
|SIS fundamental statistics|
Is SIS overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SIS income statement (TTM)|
|Cost of Revenue||UK£35.61m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.092|
|Net Profit Margin||-18.70%|
How did SIS perform over the long term?See historical performance and comparison
Is SIS undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 3/6
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SIS?
Other financial metrics that can be useful for relative valuation.
|What is SIS's n/a Ratio?|
Price to Sales Ratio vs Peers
How does SIS's PS Ratio compare to its peers?
|SIS PS Ratio vs Peers|
|Company||PS||Estimated Growth||Market Cap|
VLG Venture Life Group
BAR Brand Architekts Group
SIS Science in Sport
Price-To-Sales vs Peers: SIS is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (10.3x).
Price to Earnings Ratio vs Industry
How does SIS's PE Ratio compare vs other companies in the European Personal Products Industry?
Price-To-Sales vs Industry: SIS is good value based on its Price-To-Sales Ratio (0.3x) compared to the European Personal Products industry average (1.4x)
Price to Sales Ratio vs Fair Ratio
What is SIS's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PS Ratio||0.3x|
|Fair PS Ratio||0.8x|
Price-To-Sales vs Fair Ratio: SIS is good value based on its Price-To-Sales Ratio (0.3x) compared to the estimated Fair Price-To-Sales Ratio (0.8x).
Share Price vs Fair Value
What is the Fair Price of SIS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate SIS's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate SIS's fair value for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
How is Science in Sport forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Future Growth Score1/6
Future Growth Score 1/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SIS is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: SIS is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: SIS is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: SIS's revenue (14.5% per year) is forecast to grow faster than the UK market (4.4% per year).
High Growth Revenue: SIS's revenue (14.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SIS's Return on Equity is forecast to be high in 3 years time
Discover growth companies
How has Science in Sport performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SIS is currently unprofitable.
Growing Profit Margin: SIS is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: SIS is unprofitable, and losses have increased over the past 5 years at a rate of 10.4% per year.
Accelerating Growth: Unable to compare SIS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SIS is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (27.8%).
Return on Equity
High ROE: SIS has a negative Return on Equity (-32.62%), as it is currently unprofitable.
Discover strong past performing companies
How is Science in Sport's financial position?
Financial Health Score3/6
Financial Health Score 3/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: SIS's short term assets (£20.8M) exceed its short term liabilities (£17.9M).
Long Term Liabilities: SIS's short term assets (£20.8M) exceed its long term liabilities (£15.4M).
Debt to Equity History and Analysis
Debt Level: SIS's net debt to equity ratio (16.1%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if SIS's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if SIS has enough cash runway based on its current free cash flow.
Forecast Cash Runway: SIS has less than a year of cash runway if free cash flow continues to reduce at historical rates of 8.5% each year
Discover healthy companies
What is Science in Sport current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Cash Flow Coverage
Dividend Yield vs Market
|Science in Sport Dividend Yield vs Market|
|Company (Science in Sport)||n/a|
|Market Bottom 25% (GB)||2.1%|
|Market Top 25% (GB)||6.0%|
|Industry Average (Personal Products)||2.2%|
|Analyst forecast in 3 Years (Science in Sport)||0%|
Notable Dividend: Unable to evaluate SIS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SIS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if SIS's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SIS's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as SIS has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Mr. Stephen N. Moon, also known as Steve, MBA serves as the Chief Executive Officer of Science in Sport plc. Mr. Moon served as the Chief Executive Officer of Provexis plc since July 24, 2006. He founded a...
CEO Compensation Analysis
|Steve Moon's Compensation vs Science in Sport Earnings|
|Date||Total Comp.||Salary||Company Earnings|
|Jun 30 2022||n/a||n/a|
|Mar 31 2022||n/a||n/a|
|Dec 31 2021||UK£1m||UK£294k|
|Sep 30 2021||n/a||n/a|
|Jun 30 2021||n/a||n/a|
|Mar 31 2021||n/a||n/a|
|Dec 31 2020||UK£793k||UK£274k|
|Sep 30 2020||n/a||n/a|
|Jun 30 2020||n/a||n/a|
|Mar 31 2020||n/a||n/a|
|Dec 31 2019||UK£706k||UK£286k|
|Sep 30 2019||n/a||n/a|
|Jun 30 2019||n/a||n/a|
|Mar 31 2019||n/a||n/a|
|Dec 31 2018||UK£1m||UK£270k|
|Sep 30 2018||n/a||n/a|
|Jun 30 2018||n/a||n/a|
|Mar 31 2018||n/a||n/a|
|Dec 31 2017||UK£925k||UK£230k|
|Sep 30 2017||n/a||n/a|
|Jun 30 2017||n/a||n/a|
|Mar 31 2017||n/a||n/a|
|Dec 31 2016||UK£956k||UK£200k|
|Sep 30 2016||n/a||n/a|
|Jun 30 2016||n/a||n/a|
|Mar 31 2016||n/a||n/a|
|Dec 31 2015||UK£196k||UK£194k|
Compensation vs Market: Steve's total compensation ($USD1.18M) is above average for companies of similar size in the UK market ($USD334.29K).
Compensation vs Earnings: Steve's compensation has increased whilst the company is unprofitable.
Experienced Board: SIS's board of directors are considered experienced (7.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
|Owner Type||Number of Shares||Ownership Percentage|
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
|Ownership||Name||Shares||Current Value||Change %||Portfolio %|
Science in Sport plc's employee growth, exchange listings and data sources
- Name: Science in Sport plc
- Ticker: SIS
- Exchange: AIM
- Founded: 1992
- Industry: Personal Products
- Sector: Household
- Implied Market Cap: UK£21.363m
- Shares outstanding: 133.52m
- Website: https://www.scienceinsport.com
Number of Employees
- Science in Sport plc
- 16-18 Hatton Garden
- 2nd Floor
- Greater London
- EC1N 8AT
- United Kingdom
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|SIS||AIM (London Stock Exchange AIM Market)||Yes||New Ordinary Shares||GB||GBP||Aug 2013|
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/10/03 00:00|
|End of Day Share Price||2022/10/03 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.